
MET · NYSE
MetLife is an insurer that generates revenue from insurance and retirement-related offerings. The supplied evidence identifies Group Benefits and Retirement & Income Solutions as important businesses, while broader insurer profitability is linked to premiums, investment income and underwriting performance. Its customers are not specified in the supplied material, so the evidence does not support a more precise customer breakdown. MetLife reports $2.4 billion of revenue and $3.2 billion of net income for fiscal 2025, compared with $2.2 billion of revenue and $4.2 billion of net income in fiscal 2024.
MetLife fell $1.36, or 1.40%, from $97.49 to $96.13 over the supplied week. The stock slipped to $97.02 on July 29, briefly recovered to $97.07 on July 30, then suffered its largest decline on July 31, closing at $96.13. It edged up to $96.31 on August 3 before giving back that gain on August 4. The evidence does not identify a company-specific announcement driving the move. Instead, trading occurred ahead of second-quarter results, with coverage focused on whether Group Benefits strength and rising earnings estimates could offset uncertainty around investment income, commercial pricing and underwriting trends.